ResearchMoz

Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-10-10
No. Of Pages » 88
 Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacological and non-pharmacological treatment products used for the treatment of AF.  
   
 The pharmacological AF treatment market has been further classified into the specific drugs commonly used for treating AF, namely anti-arrythmics and anti-coagulants....
Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
1.3 Research methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rising global base of geriatric population
3.2.1.2 Favorable results exhibited by clinical trials aimed at treating atrial fibrillation
3.2.1.3 Rising prevalence of disorders such as hypertension and obesity accelerating the incidence rate of atrial fibrillation
3.2.2 Restraints
3.2.2.1 Stringent FDA, CE and European Medicines Agency product approval regulations
3.2.3 Opportunities
3.2.3.1 Introduction of innovative treatment procedures
3.2.3.2 Rising prevalence of atrial fibrillation in emerging Asian economies
3.3 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Competitive Rivalry

Chapter 4 Atrial Fibrillation Market, by Treatment Types
4.1 Overview
4.1.1 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.2 Global Pharmacological Treatments for Atrial Fibrillation Market
4.2.1 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.2.2 Global Anti-Arrhythmic Drugs Market
4.2.2.1 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million)
4.2.3 Global Anti-Coagulants Market
4.2.3.1 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3 Non-Pharmacological Treatment for Atrial Fibrillation Market
4.3.1 Overview: Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
4.3.2 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3 Global Catheter Ablation Treatment for Atrial Fibrillation Market
4.3.3.1 Overview
4.3.3.2 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.3 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.4 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.5 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.6 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.3.7 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.4 Global Maze Surgery for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
4.3.5 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million)

Chapter 5 Atrial Fibrillation Market, by Geography
5.1 Overview
5.2 North America
5.2.1 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape

Chapter 7 Recommendations
7.1 Investing in emerging markets, particularly China and Brazil
7.2 Focus on emerging technologies such as mini-maze procedure and catheter ablation

Chapter 8 Company Profiles
8.1 AtriCure, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.2 Biosense Webster, Inc.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.3 Boehringer Ingelheim GmbH
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 Bristol-Myers Squibb Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.6 CardioFocus, Inc.
8.6.1 Company Overview
8.6.2 Product Portfolio
8.7 Endoscopic Technologies, Inc.
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Business Strategies
8.8 Sanofi Aventis
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.9 St. Jude Medical, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.10 Johnson and Johnson Ltd
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies

List of Tables


TABLE 1 Market Snapshot: Global Atrial Fibrillation Market
TABLE 2 Impact analysis of the Market Drivers for the Global Atrial Fibrillation Market
TABLE 3 Impact analysis of the Market Restraints for the Global Atrial Fibrillation Market
TABLE 4 Anti-Arrhythmic Drug Types and Clinical Usage
TABLE 5 Anti-Arrhythmic Drugs: Classification and Clinical Usage
TABLE 6 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 7 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 8 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 
TABLE 9 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)

List of Figures

FIG. 1 Market Segmentation: Global Atrial Fibrillation Market
FIG. 2 Global Atrial Fibrillation Market, by Treatment Types, 2012 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market
FIG. 5 Comparative Analysis of the Global Atrial Fibrillation Market, by Treatment Types, 2012 & 2019 (%)
FIG. 6 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 7 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 8 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million)
FIG. 9 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 10 Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
FIG. 11 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 12 Comparative Analysis: Catheter Ablation Treatment Types for the Atrial Fibrillation Market
FIG. 13 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 14 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 15 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 16 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 17 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 18 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 19 Global Maze Surgery for Atrial Fibrillation Market, 2013 – 2019 (USD Million)
FIG. 20 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 21 Comparative Analysis of the Global Atrial Fibrillation Market, by Geography, 2012 & 2019 (%)
FIG. 22 North America Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 23 Europe Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 24 Asia-Pacific Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 25 RoW Atrial Fibrillation Market, 2011 – 2019 (USD Million)
FIG. 26 AtriCure Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Boehringer Ingelheim: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Boston Scientific: Annual sales revenue, 2010 – 2012 (USD Million)
FIG. 29 Bristol-Myers Squibb: Annual sales revenue, 2010 – 2012 (USD Million)
FIG. 30 Sanofi: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 St. Jude Medical: Annual Sales Revenue,2010 – 2012 (USD Million)
FIG. 32 Johnson and Johnson: Annual Revenue, 2010 – 2012 (USD Million)

Upcoming Reports:

Gonorrhea Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Gonorrhea is a contagious sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae. The disease can also pass on to a new born through infected mother during parturition. This disease can affect both men and women. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes and urethra. In addition, the bacterium can also grow in the throat, mouth and anus. According to Center for Disease Control (CDC), in 2010 the total number of people suffering from gonorrhea was estimated to be around 3 lacs in the U.S. Diagnostic tests for...
DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
By - Transparency Market Research
Vaccines have been in use since decades to provide immunological responses against diseases. A conventional vaccine is a biological preparation of weakened or attenuated, killed forms of a microbe or one of its cellular components, while a DNA vaccine is composed of genetically engineered DNA. When a DNA vaccine is injected into the cells of an organism, it stimulates organism’s immune system to produce immunity against the encoded antigens. DNA vaccines have a number of advantages over conventional vaccines such as when a conventional vaccine is administered, it activates only...
Dimethoate Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Dimethoate is organophosphate insecticide used to eliminate insects by affecting its central nervous system. It has systemic and contact activity against wide range of piercing, chewing and sucking insects. Dimethoate is specifically used to control aphids, thrips, mites, whiteflies and other pests. The crops on which it is used include cotton, fruits, citrus, tobacco, tea, potatoes and other vegetables. Dimethoate can be also used to control flies in livestock, food storage and home gardens.  Growing food demand across the globe is expected to drive the market for dimethoate...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

World Cup Stadium at Qatar to be Renovated for 2022 FIFA World Cup
Nov 26, 2014  
The design for renovation of the Khalifa International Stadium will soon be unveiled by the organization that is responsible for building the infrastructure and stadiums for the 2022 FIFA World Cup Qatar. The main construction work on the stadium is being looked into by two prominent construction companies. The joint venture is between Six Construct and Midmac Contracting. Six Construct is a...
DOD Spending Low, Corps Look for More Work in Alaska
Nov 24, 2014  
Military construction across Alaska continues to decline. Government contractors expect to keep busy for the time being with work delegated by other federal agencies. The United States Army Corps of Engineers expects to have more than US$410 million worth of work available on at least 400 projects in the 2015 fiscal year. Chris Tew, the Alaska Contracting Division chief said that is...
China Consumer Products Fair Kicks-Off in Abu Dhabi
Nov 24, 2014  
Seeking to market products in the United Arab Emirates (UAE) and Mena regions, more than 100 consumer goods makers from China showcased their mid-to-high-end consumer goods at the China Consumer Products Fair. The second edition of the China Consumer Products Fair 2014 began on Monday in Abu Dhabi’s National Exhibition Center (Adnec). The event was officially inaugurated by the Economic...
Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...